- Drug Coverage
- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Safety & Recalls
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Clinician Challenges In Infertility Diagnosis
Joseph Chervenak, MD, MBA, begins a discussion surrounding innovative processes in reproductive medicine.
EP: 1.Clinician Challenges In Infertility Diagnosis
EP: 2.Emerging Trends and Technology Within Reproductive Medicine Landscape
EP: 3.Evaluating Access to Care and Service Coverage Associated With Reproductive Medicine
EP: 4.Availability of Coverage Impacting Patients Seeking Infertility Treatment
EP: 5.Strategies for Navigating Socioeconomic Factors In Reproductive Medicine
EP: 6.Optimizing Health Benefit Design and Patient Outcomes In Infertility Management
Joseph Chervenak, MD, MBA, discusses the complexities in diagnosing infertility, highlighting the challenge of fitting individual experiences into clinical definitions. The American Society of Reproductive Medicine (ASRM) redefined infertility to be more inclusive, acknowledging diverse patient needs, including those of same-sex couples. The primary hurdle in treatment lies in the prohibitive cost of in vitro fertilization (IVF), despite its high success rates. The discussion emphasizes the psychosocial strains during IVF, such as financial burdens and lacking support systems for patients. Additionally, the expert explores the limitations faced by vulnerable populations, like cancer patients, who struggle with the potential risks to their reproductive health due to the toxicity of cancer treatments. The concept of "financial toxicity" impacting quality of life due to medical expenses is highlighted, prompting a call for more comprehensive evaluation and investment in psychological support services in the field of reproductive health. The importance of not solely focusing on technology but also emphasizing the human aspect of care is underscored, advocating for a holistic approach.
Video synopsis is AI-generated and reviewed by Managed Health Care Executive editorial staff.
Fertility Treatments Found to Be Equally Effective in Females with PCOS as in Those Without
December 18th 2023In a study recently published in the journal Fertility and Sterility, researchers from the University of Queensland in Brisbane, Australia, evaluated the fertility treatment pathways used by participants with and without PCOS to determine which pathways resulted in more live births.
Read More
Air Pollution May Negatively Affect Male Reproductive Health
November 30th 2023A potential mechanism by which air pollutants may affect reproductive health is by endocrine disruption. Air pollutants are made up of mixtures of particulate matter that may include endocrine disruptors, such as polycyclic aromatic hydrocarbons (PAHs) and heavy metals.
Read More
